
معرفی
Professor Donald Fraser serves as Director of the Division of Infection and Immunity and Director of the Wales Kidney Research Unit within Cardiff University's School of Medicine. Clinically active as a consultant nephrologist at Cardiff and Vale University Health Board, he leads internationally recognized research on kidney injury mechanisms and fibrosis in chronic kidney disease and peritoneal dialysis contexts.
His educational background includes an MB ChB from the University of Bristol (1993), membership in the Royal College of Physicians (1996), PhD from University of Wales College of Medicine (2003), and Certificate of Completion of Training in General Medicine and Nephrology (2006).
Fraser's research program investigates fibro-proliferative disorders through multiple approaches:
- MicroRNA biomarker discovery for kidney disease progression
- Mechanisms of peritoneal membrane injury during dialysis
- Inflammatory pathways in renal scarring
- Translational models of kidney fibrosis
Analysis of his 15 most recent publications reveals strong emphasis on molecular mechanisms of kidney injury (73%), biomarker development (60%), and translational models (47%), with increasing integration of single-cell technologies and machine learning approaches since 2021.
Key recognitions include:
- Health and Care Research Wales Lead Researcher (2013)
- American Society of Nephrology Travel Scholarship (2011)
- Sir Jules Thorne Scholarship (2010)
- Clinician Scientist Fellowship (2005)
- Kidney Research UK Clinical Training Fellowship (2000)
As an academic supervisor, Fraser currently leads one PhD student as principal supervisor and four as cosupervisor, having previously guided 12 doctoral candidates to completion. His research program receives consistent funding from Health and Care Research Wales and Kidney Research UK, with recent projects focusing on peritoneal dialysis outcomes and microRNA-based diagnostics.
He directs the Wales Kidney Research Unit's All-Wales strategy for kidney disease research and co-leads the Division of Infection and Immunity's internationally cited research program spanning basic immunology to clinical applications in human health.




